Yuuri Hashimoto

4.0k total citations · 1 hit paper
91 papers, 2.3k citations indexed

About

Yuuri Hashimoto is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Yuuri Hashimoto has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Molecular Biology and 23 papers in Genetics. Recurrent topics in Yuuri Hashimoto's work include Virus-based gene therapy research (23 papers), Cancer Research and Treatments (19 papers) and RNA Interference and Gene Delivery (11 papers). Yuuri Hashimoto is often cited by papers focused on Virus-based gene therapy research (23 papers), Cancer Research and Treatments (19 papers) and RNA Interference and Gene Delivery (11 papers). Yuuri Hashimoto collaborates with scholars based in Japan, United States and Australia. Yuuri Hashimoto's co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Yasuo Urata, Futoshi Uno, Hiroshi Tazawa, Amy B. Heimberger, Yuichi Watanabe, Shouhao Zhou, Shinji Kuroda and Gregory N. Fuller and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Yuuri Hashimoto

91 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

2018 287 citations Jun Wei, Anantha Marisetty et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuuri Hashimoto Japan	24	834	776	589	568	455	91	2.3k
Syed R. Husain United States	30	688 0.8×	772 1.0×	1.2k 2.0×	204 0.4×	376 0.8×	54	2.5k
Sandrine Valsesia‐Wittmann France	19	1.4k 1.6×	1.5k 2.0×	788 1.3×	407 0.7×	133 0.3×	24	2.7k
Andrew Wilber United States	28	1.7k 2.0×	895 1.2×	387 0.7×	556 1.0×	74 0.2×	62	2.8k
Hidefumi Hiramatsu Japan	19	834 1.0×	699 0.9×	917 1.6×	416 0.7×	92 0.2×	95	2.7k
Yoko Oei United States	12	1.4k 1.6×	1.1k 1.4×	1.9k 3.3×	170 0.3×	165 0.4×	17	3.6k
Toru Nishi Japan	25	750 0.9×	226 0.3×	247 0.4×	214 0.4×	379 0.8×	70	2.0k
Hideo Takeshima Japan	25	765 0.9×	248 0.3×	207 0.4×	180 0.3×	327 0.7×	123	2.3k
R Rampling United Kingdom	23	778 0.9×	810 1.0×	151 0.3×	1.0k 1.8×	152 0.3×	49	2.7k
G. Scott Herron United States	23	984 1.2×	427 0.6×	228 0.4×	204 0.4×	87 0.2×	34	3.4k
Karen Clise-Dwyer United States	23	795 1.0×	781 1.0×	1.1k 1.8×	329 0.6×	72 0.2×	54	2.2k

Countries citing papers authored by Yuuri Hashimoto

Since Specialization

Citations

This map shows the geographic impact of Yuuri Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuuri Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuuri Hashimoto more than expected).

Fields of papers citing papers by Yuuri Hashimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuuri Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuuri Hashimoto. The network helps show where Yuuri Hashimoto may publish in the future.

Co-authorship network of co-authors of Yuuri Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuuri Hashimoto. A scholar is included among the top collaborators of Yuuri Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuuri Hashimoto. Yuuri Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ott, Martina, Cynthia Kassab, Anantha Marisetty, et al.. (2020). Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clinical Cancer Research. 26(18). 4983–4994. 41 indexed citations

Qin, Yong, Jason Roszik, Chandrani Chattopadhyay, et al.. (2016). Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. Molecular Cancer Therapeutics. 15(10). 2442–2454. 41 indexed citations

Takehara, Kiyoto, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2015). Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer. Molecular Cancer Therapeutics. 15(1). 199–208. 18 indexed citations

Tanese, Keiji, Yuuri Hashimoto, Zuzana Berkova, et al.. (2015). Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ. Journal of Investigative Dermatology. 135(11). 2775–2784. 72 indexed citations

Shigeyasu, Kunitoshi, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2014). Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics. Gut. 64(4). 627–635. 22 indexed citations

Hasei, Joe, Tsuyoshi Sasaki, Hiroshi Tazawa, et al.. (2013). Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells. Molecular Cancer Therapeutics. 12(3). 314–325. 53 indexed citations

Yano, Shuya, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2013). A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases. Clinical Cancer Research. 19(23). 6495–6505. 64 indexed citations

Tazawa, Hiroshi, Yuuri Hashimoto, Shuya Yano, et al.. (2012). Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells. Cancer Immunology Immunotherapy. 61(11). 1905–1916. 22 indexed citations

Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2012). Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 124(2). 105–110. 1 indexed citations

10.

Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2011). Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas. Clinical Cancer Research. 17(7). 1828–1838. 43 indexed citations

11.

Kuroda, Shinji, Toshiya Fujiwara, Yasuhiro Shirakawa, et al.. (2010). Telomerase-Dependent Oncolytic Adenovirus Sensitizes Human Cancer Cells to Ionizing Radiation via Inhibition of DNA Repair Machinery. Cancer Research. 70(22). 9339–9348. 61 indexed citations

12.

Sakai, Ryo, Shunsuke Kagawa, Toru Kojima, et al.. (2010). Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer. Molecular Cancer Therapeutics. 9(6). 1884–1893. 18 indexed citations

13.

Liu, Dong, Toru Kojima, Masaaki Ouchi, et al.. (2009). Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. Molecular Cancer Therapeutics. 8(4). 980–987. 40 indexed citations

14.

Ikeda, Yoshihiro, Toru Kojima, Shinji Kuroda, et al.. (2009). A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System. The Journal of Immunology. 182(3). 1763–1769. 16 indexed citations

15.

Hashimoto, Yuuri, Yuichi Watanabe, Futoshi Uno, et al.. (2008). Establishment of biological and pharmacokinetic assays of telomerase‐specific replication‐selective adenovirus. Cancer Science. 99(2). 385–390. 57 indexed citations

16.

Hashimoto, Yuuri, N. Matsuoka, Atsushi Kawakami, et al.. (2001). Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clinical & Experimental Immunology. 125(1). 19–24. 28 indexed citations

17.

Hirota, Kazuyoshi, Tosiya Sato, Yuuri Hashimoto, et al.. (1999). Relaxant effect of propofol on the airway in dogs. British Journal of Anaesthesia. 83(2). 292–295. 14 indexed citations

18.

Shima, T, et al.. (1996). [A fluoroscopic analysis of the catheters abnormally placed in the epidural space].. PubMed. 45(1). 66–9. 1 indexed citations

19.

Suzuki, Shuji, et al.. (1995). Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells. British Journal of Cancer. 72(3). 663–668. 20 indexed citations

20.

Seko, Yoshinori, Hiroaki Matsuda, Kiminori Kato, et al.. (1993). Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.. Journal of Clinical Investigation. 91(4). 1327–1336. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact